BIO announces program for BIO India International Conference.
Share:
Press Release Summary:
During BIO India International Conference, biotechnology and pharmaceutical companies from North America, Europe, and Asia will come together to explore business opportunities with India's biotech sector. Event will feature 1-on-1 partnering, plenary and panel sessions, company presentations, and exhibiting and networking opportunities. Industry leaders will discuss innovation and financing, global biopharma, and high-profile deal between multi-national pharma and Indian biotech company.
Original Press Release:
BIO Announces Program for BIO India International Conference
BIO India event will be held September 21 - 22 in Hyderabad, India
WASHINGTON & HYDERABAD, India - The Biotechnology Industry Organization (BIO) today announces the program for the BIO India International Conference to be held September 21 - 22 at the Hyderabad International Convention Centre in Hyderabad, India. This exclusive forum will bring together biotechnology and pharmaceutical companies from North America, Europe and Asia to meet and explore business opportunities with India's emerging biotech sector.
After a successful inaugural BIO India International Conference in 2010 featuring over 200 companies, biotechnology and pharmaceutical companies from North America, Europe and Asia are returning to Hyderabad this September. BIO India will feature BIO One-on-One Partnering, plenary and panel sessions, company presentations and exhibiting and networking opportunities.
BIO India attendees will have the opportunity to hear keynote addresses both days of the conference. Keynote speakers will include Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals; Aaron Schacht, Executive Director and COO, Global External R&D, Eli Lilly & Company; Vivek Mohan, President of Services at Alcatel-Lucent; and Cartikeya Reddy, Senior Vice-President and Head, Biologics, Dr. Reddy's Laboratories Ltd.
The BIO India conference also will feature industry leaders discussing innovation and financing, global biopharma and examining a high-profile deal between a multi-national pharma and an Indian biotech company. Panel sessions highlight the latest issues and trends related to doing business in India. BIO India sessions will include:
Cross-Cultural Deal Making-Diving into Pfizer-Biocon
In late 2010, Pfizer and Biocon announced their insulin marketing and development collaboration, worth up to $350 M dollars. The deal has provided Pfizer with a foothold in India, and placed the companies at the center of the global biosimilar insulin marketplace, valued at $14 B per year. This panel features operational leaders from both companies engaging in a candid discussion covering the deal's structure, the collaboration's progress and the dynamics of cross-cultural dealmaking.
Wednesday, September 21st, 5:30pm - 6:30pm
Moderator: Alan Eisenberg, EVP, Emerging Companies and Business Development, BIO
Panelists: Arun Chandavarkar, COO, BIOCON and Matthew Walker, VP of Operations, Specialty/Biotechnology Operating Unit, Pfizer
Beyond Outsourcing - Uncovering Innovation in India
Recent high-profile deals between Indian biotech companies and multinational biopharmas have proved that India's growing biotechnology sector is a source for R&D collaborations and innovative treatments. So, what exactly is being innovated in India's biotech labs? What forms does this innovation take? Which companies and biotech sectors are most innovative? How does India's biotechnology innovation differ from traditional NME-driven Western innovation? Panelists will discuss their experiences in India's innovative biotech space.
Thursday, September 22nd, 9:30am - 10:30am
Moderator: Glen Giovannetti, Global Biotechnology Leader, Ernst & Young
Panelists: Suri Venkatachalam, CEO and Managing Director, Connexios Life Sciences
Vijay Chandru, CEO, Strand Life Sciences
Mallikarjun Sundaram, President and CEO, Mitra Biotech Ltd.
Sanuj Ravindran, Managing Director, Asian Healthcare Management, Ltd.
Strategic Roadmap for India: A Discourse Among Global Pharma Executives
A set of Western multinational pharmas have made business deals with Indian companies and institutions, but what are their long-term intentions in India? Hear senior biopharma executives discuss their India roadmaps with Indian biotech leaders.
Thursday, September 22nd, 12:30pm - 2:30pm
Moderator: Sri Mosur, CEO, Jubilant Biosys
Panelists: Bala Ganesh Tanjore, Head of Research, VP of Discovery, Astra Zeneca
Yetunde Taiwo, Senior Director, Emerging Markets, Eli Lilly & Company
Anand Gautam, Director, Biopharmaceutical Sourcing, Novo Nordisk
Swami Subramaniam, Director, External Research and Licensing, Merck Research Laboratories, Merck
Throughout the Conference, senior executives from the industry's most important biotech and pharma companies will be seeking Indian companies for potential partnerships and discovery and development deals, or those who can provide high-quality contract research, manufacturing or clinical trials support.
For more information on BIO India, please visit www3.bio.org/bioindia/?q=bioindia/.
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, a multiblog platform and monthly newsletter that aims to create an online biotech community where the the industry can connect to discuss the latest news. Subscribe to BIOtechNOW.
For more information:
Visit www.bio.org
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech
Contacts
Biotechnology Industry Organization (BIO)
India Contact:
Srinivas Ram, +91 9000793986
srinivas@slokapr.com
or
U.S. Contact:
Abigail Hirsch, 202-962-9235
ahirsch@bio.org
